Waters Corporation launched the Waters SYNAPT MS system, a next-generation quadrupole acceleration, time-of-flight (qa-Tof) mass spectrometry (MS) platform. The SYNAPT MS system provides an upgrade pathway to the SYNAPT High Definition MS (HDMS) system, enabling researchers to analyze samples differentiated by size, shape and charge, as well as mass, ultimately providing new capabilities that can help them meet and exceed future requirements.
SYNAPT MS is a central component of Waters’ system level solutions—combining ACQUITY UltraPerformance LC (UPLC) separations, Exact Mass MSE data acquisition and ‘chemically intelligent’ MassLynx Informatics—designed to generate high-quality, comprehensive data from complex biological samples.
This article was published in Drug Discovery & Development magazine: Vol. 11, No. 2, February, 2008, pp. 8.
Filed Under: Drug Discovery